Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, Multi-center Collaborative Study to Evaluate the Efficacy of Magnesium Isoglycyrrhizinate Injection in the Prevention of Antineoplastic Chemotherapy Related Acute Liver Injury

NCT01802996 is registered in ClinicalTrials.gov with Cttq as lead sponsor.

NCT NCT01802996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01802996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, Multi-center Collaborative Study to Evaluate the Efficacy of Magnesium Isoglycyrrhizinate Injection in the Prevention of Antineoplastic Chemotherapy Related Acute Liver Injury
Lead sponsor
Cttq
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2013
Completion date
August 31, 2014
Enrollment
2,040 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

liver injury, neoplasms